Holistic Approach in the Treatment of Actinic Keratosis: Benefits and Disadvantages of 5-Fluorouracil, Imiquimod, Diclofenac and Curaderm

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.net/journal/ijcm
E-mail: [email protected]

Citations

"Holistic Approach in the Treatment of Actinic Keratosis: Benefits and Disadvantages of 5-Fluorouracil, Imiquimod, Diclofenac and Curaderm"
written by Bill Elliot Cham,
published by International Journal of Clinical Medicine, Vol.14 No.7, 2023

has been cited by the following article(s):

[1]	The Value of Excipients and the Required Understanding of the Biological System in Product Development: An Impactful Example of Curaderm, a Topical Skin Cancer …
	International Journal of …, 2024

[2]	Gold Standard for Skin Cancer Treatment: Surgery (Mohs) or Microscopic Molecular-Cellular Therapy (Curaderm)?
	Journal of Cancer Therapy, 2024

[1]	Transdermal drug delivery systems in cancer therapy: advances, challenges, and future perspectives European Journal of Clinical Pharmacology, 2026 DOI:10.1007/s00228-026-04086-8

[2]	Artificial Intelligence-Assisted Dermatologic Screening: Epidemiology and Clinical Features of Basal Cell Carcinoma, Squamous Cell Carcinoma, Seborrheic Keratosis and Actinic Keratosis Bioengineering, 2025 DOI:10.3390/bioengineering12111258

[3]	Enhanced Analysis and Simplification of Scientific Findings with Emphasis on Katabasis and Anabasis on Safe and Effective Skin Cancer Treatment Using Curaderm Journal of Cancer Therapy, 2025 DOI:10.4236/jct.2025.164011

[4]	Gold Standard for Skin Cancer Treatment: Surgery (Mohs) or Microscopic Molecular-Cellular Therapy (Curaderm)? Journal of Cancer Therapy, 2024 DOI:10.4236/jct.2024.152004

[5]	The Value of Excipients and the Required Understanding of the Biological System in Product Development: An Impactful Example of Curaderm, a Topical Skin Cancer Treatment International Journal of Clinical Medicine, 2024 DOI:10.4236/ijcm.2024.152005